Background The current TNM classification that simply classifies differentiated thyroid
carcinoma (DTC) patients younger than 55 years into stage I and stage II based on the …

Objective Age> 45 years is included as a variable in the tumor, node, metastases (TNM)
staging of differentiated thyroid cancer (DTC), but a higher cut‐off value has been suggested …

Objective Age is integrated in most risk stratification systems for well-differentiated thyroid
cancer (WDTC). The most appropriate age threshold for stage grouping of WDTC is …

Objective Although the age at diagnosis has been suggested as a major determinant of
disease-specific survival in the recent TNM staging system, it is not included in the recent …

Purpose The current tumor, node, metastasis (TNM) system uses an age of 55 years as a
threshold for differentiated thyroid cancer (DTC). The aim of our study was to explore the …

Background The aim of this study was to evaluate the prognostic veracity for disease-
specific survival (DSS) of the eighth edition of the American Joint Committee on …

Background. The 8th edition of the American Joint Committee on Cancer (AJCC) staging
system changed the age cutoff for risk stratification of differentiated thyroid carcinoma (DTC) …

Objective: The 8th TNM system edition (TNM-8) released in 2018 presents significant
changes when compared to the 7th edition (TNM-7). The aim of this study was to assess the …

Background This study aimed to establish and validate an accurate prognostic model, based
on demographic and clinical parameters, for predicting the cancer-specific survival (CSS) of …

Well-differentiated thyroid carcinoma (WDTC) represents a group of thyroid cancers with
excellent prognosis. Age, a well-recognized risk factor for WDTC, has been consistently …